Taken together, our findings identified a novel molecular mechanism involved in modulating mTOR activity and a previously unidentified potential pathway contributing to PTEN/PI3K/AKT-independent increase of mTOR activity observed in a subset of cancers. Here, MTOR is linked to cancer.